Can herbs provide a new generation of drugs for treating Alzheimer’s disease?
Abstract
The overall aim of this review is to discuss cellular mechanisms at work in the progression of AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of herbal treatments. Recent advances in molecular, cellular, and animal model studies have revealed that formation of the 4-kDa amyloid beta peptide is a key factor in the development and progression of AD. Several cellular changes have been identified that are related to amyloid beta plaques and neurofibrillary tangles found in the autopsied brains of AD patients and in AD animal models. Several therapeutic strategies have been developed to treat AD, including anti-inflammatory, anti-oxidant, and anti-amyloid approaches. Recently, herbal treatments have been tested in animal and cellular models of AD and in clinical trials with AD subjects. In AD animal models and cell models, herbal extracts appear to have fewer adverse effects than beneficial effects on A beta and cognitive functions. These extracts have multi-functional properties (pro-cholinergic, anti-oxidant, anti-amyloid, and anti-inflammatory), and their use in the treatment of AD patients looks promising. The chemical compositions of herbs and their potential for alleviating or reducing symptoms of AD or for affecting the disease mechanism need to be further studied.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The worldwide increasing tendency toward using phytochemicals may be due to low toxicity and synergistic effects.
“The worldwide increasing tendency toward using phytochemicals may be due to low toxicity, and synergistic effects [199,200,201].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [199]
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219 · see citing works
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E. C., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. M. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,074 · see citing works
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016 · see citing works
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Williamson, G., & Manach, C. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.243s · Cited by 1,340 · see citing works
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · see citing works
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298 · see citing works
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254 · see citing works
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114 · see citing works
Synergy and other interactions in phytomedicines
WILLIAMSON, E. (2001) · Phytomedicine · doi:10.1078/0944-7113-00060 · Cited by 1,027 · see citing works
Herbal Medicines and Perioperative Care
Ang-Lee, M. K. (2001) · JAMA · doi:10.1001/jama.286.2.208 · Cited by 981 · see citing works
Plants and human health in the twenty-first century
Raskin, I., Ribnicky, D., Komarnytsky, S., Ilić, N., Poulev, A., Borisjuk, N. V., Brinker, A., Moreno, D. A., Ripoll, C., Yakoby, N., et al. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(02)02080-2 · Cited by 915 · see citing works
The Pharmacology of Chinese Herbs
Huang, K. (1998) · Routledge eBooks · doi:10.4324/9780367801892 · Cited by 877 · see citing works
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789 · see citing works
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780 · see citing works
Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y., Mandelkow, E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002466200 · Cited by 730 · see citing works
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · see citing works
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644 · see citing works
ApoE genotype accounts for the vast majority of AD risk and AD pathology
Raber, J., Huang, Y., & Ashford, J. W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.023 · Cited by 599 · see citing works
Anandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571 · see citing works
DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., & Holtzman, D. M. (2002) · Science · doi:10.1126/science.1067568 · Cited by 563 · see citing works
Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556 · see citing works
de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7106 · Cited by 552 · see citing works
Qiu, W. Q., & Folstein, M. F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.004 · Cited by 538 · see citing works
Self-Assembly of Aβ <sub>1</sub> <sub>-</sub> <sub>42</sub> into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522 · see citing works
New Frontiers in Alzheimer's Disease Genetics
Tanzi, R. E., & Bertram, L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00476-7 · Cited by 464 · see citing works
Howes, M. R., & Houghton, P. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00128-x · Cited by 443 · see citing works
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436 · see citing works
Youdim, K. A., & Joseph, J. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00510-4 · Cited by 434 · see citing works
Mańczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 432 · see citing works
Howes, M. R., Perry, N. S. L., & Houghton, P. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1280 · Cited by 418 · see citing works
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A. J., Curry, K. J., Buford, J. P., Khan, I. A., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 399 · see citing works
Ballard, C. G., O'Brien, J. T., Reichelt, K., & Perry, E. K. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0703 · Cited by 396 · see citing works
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J.-H. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 391 · see citing works
Perry, N. S. L., Bollen, C. S. C., Perry, E. K., & Ballard, C. G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00108-4 · Cited by 384 · see citing works
Bastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 378 · see citing works
Youdim, K. A., Shukitt‐Hale, B., & Joseph, J. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.002 · Cited by 373 · see citing works
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
Reddy, P. H., Mani, G., Park, B. S., Jacques, J., MURDOCH, G. H., Whetsell, W. O., Kaye, J. A., & Mańczak, M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7203 · Cited by 372 · see citing works
Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts
López, S., Bastida, J., Viladomat, F., & Codina, C. J. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02034-9 · Cited by 359 · see citing works
Plants and the central nervous system
Carlini, E. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00112-6 · Cited by 357 · see citing works
Akhondzadeh, S., Noroozıan, M., Mohammadi, M., Ohadinia, S., Jamshidi, A. H., & Khani, M. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00463.x · Cited by 345 · see citing works
Studies on molecular mechanisms of Ginkgo biloba extract
Luo, Y., & Smith, J. V. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1527-9 · Cited by 344 · see citing works
Choi, Y.-T., Jung, C., Lee, S., Bae, J., Baek, W., Suh, M., Park, J., Park, C., & Suh, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01438-2 · Cited by 342 · see citing works
Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease
Morris, M. C., Beckett, L. A., Scherr, P. A., Hebert, L. E., Bennett, D. A., Field, T. S., & Evans, D. A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00001 · Cited by 332 · see citing works
Reddy, P. H., McWeeney, S. K., Park, B. S., Mańczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R. P., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 327 · see citing works
Sharma, M., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02083-0 · Cited by 326 · see citing works
The CNS effects of Ginkgo biloba extracts and ginkgolide B
Maclennan, K. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00015-1 · Cited by 300 · see citing works
Qin, L., Liu, Y., Cooper, C. L., Liu, B., Wilson, B. C., & Hong, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01210.x · Cited by 290 · see citing works
Akhondzadeh, S. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.863 · Cited by 290 · see citing works
Are mitochondria critical in the pathogenesis of Alzheimer's disease?
Reddy, P. H., & Beal, M. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.004 · Cited by 289 · see citing works
Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. L. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772808 · Cited by 285 · see citing works
Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El‐Agnaf, O. M. A., Hartley, D. M., & Selkoe, D. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 284 · see citing works
Koldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411420200 · Cited by 279 · see citing works
Park, S., & Kim, D. S. H. L. (2002) · Journal of Natural Products · doi:10.1021/np010039x · Cited by 278 · see citing works
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
Li, F., Calingasan, N. Y., Yu, F., Mauck, W. M., Toidze, M., Almeida, C. G., Takahashi, R. H., Carlson, G. A., Beal, M. F., Lin, M. T. S., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02455.x · Cited by 276 · see citing works
Abe, K., & Saito, H. (2000) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(200005)14:3 · Cited by 271 · see citing works
Kong, A. T., Yu, R., Chen, C., Mandlekar, S., & Primiano, T. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976458 · Cited by 270 · see citing works
Solomon, P. R., Adams, F., Silver, A., Zimmer, J., & DeVeaux, R. D. (2002) · JAMA · doi:10.1001/jama.288.7.835 · Cited by 269 · see citing works
Veerendra Kumar, M., & Gupta, Y. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03842.x · Cited by 249 · see citing works
Hashimoto, M., Kazui, H., Matsumoto, K., Nakano, Y., Yasuda, M., & Mori, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.676 · Cited by 243 · see citing works
Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites
Spencer, J. P. E., Kuhnle, G., WILLIAMS, R. J., & Rice-Evans, C. A. (2003) · Biochemical Journal · doi:10.1042/bj20021972 · Cited by 241 · see citing works
Ramassamy, C., Averill‐Bates, D. A., Beffert, U., Bastianetto, S., Théroux, L., Lussier‐Cacan, S., Cohn, J. S., Christen, Y., Davignon, J., Quirion, R., et al. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00102-1 · Cited by 240 · see citing works
The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba
Watanabe, C. M. H., Wolffram, S., Ader, P., Rimbach, G. H., Packer, L., Maguire, J. J., Schultz, P. G., & Gohil, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111126298 · Cited by 234 · see citing works
Stackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230 · see citing works
Gasparini, L., Ongini, E., & Wenk, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02743.x · Cited by 226 · see citing works
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742268.x · Cited by 222 · see citing works
Immunotherapeutic Approaches to Alzheimer's Disease
Monsonego, A., & Weiner, H. L. (2003) · Science · doi:10.1126/science.1088469 · Cited by 217 · see citing works
Zangara, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00111-4 · Cited by 208 · see citing works
Nordberg, A. K., Hellström‐Lindahl, E., Lee, M., Johnson, M. A., Mousavi, M. T., Hall, R., Perry, E. K., Bednar, I., & COURT, J. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 204 · see citing works
Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study
Holmes, C., Hopkins, V., Hensford, C., MacLaughlin, V., Wilkinson, D., & Rosenvinge, H. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.593 · Cited by 202 · see citing works
Deer Browsing and Population Viability of a Forest Understory Plant
McGraw, J. B., & Furedi, M. A. (2005) · Science · doi:10.1126/science.1107036 · Cited by 200 · see citing works
Savelev, S. U., Okello, E. J., & Perry, E. K. (2004) · Phytotherapy Research · doi:10.1002/ptr.1451 · Cited by 193 · see citing works
Antioxidant strategies for Alzheimer's disease
Grundman, M., & Delaney, P. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002146 · Cited by 193 · see citing works
Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers
Tildesley, N. T. J., Kennedy, D. O., Perry, E. K., Ballard, C. G., Savelev, S. U., Wesnes, K. A., & Scholey, A. B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00122-9 · Cited by 184 · see citing works
Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183 · see citing works
Yao, Z., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181 · see citing works
Liu, C.-P., Tsai, W., Lin, Y.-L., Liao, J.-F., Chen, C., & Kuo, Y. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.019 · Cited by 179 · see citing works
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
Kitazawa, M., Yamasaki, T. R., & LaFerla, F. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.006 · Cited by 177 · see citing works
Zheng, F., Chang, Y. S., Cheng, Y., Zhang, B. W., Qu, Z., Qin, C., & Zhang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00144.x · Cited by 169 · see citing works
Schulz, V. (2003) · Phytomedicine · doi:10.1078/1433-187x-00302 · Cited by 164 · see citing works
Abbas, N., Bednar, I., Mix, E., Svedberg, M., Paterson, D., Ljungberg, A., Morris, C. M., Winblad, B. G., Nordberg, A. K., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161 · see citing works
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis‐Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P. G., Milligan, S. R., et al. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777846 · Cited by 159 · see citing works
Novel Diterpenoid Acetylcholinesterase Inhibitors fromSalvia miltiorhiza
Ren, Y., Houghton, P. J., Hider, R. C., & Howes, M. R. (2004) · Planta Medica · doi:10.1055/s-2004-815535 · Cited by 157 · see citing works
Immunotherapy for Alzheimer's disease
Gélinas, D. S., Silva, K. D., Fenili, D., George‐Hyslop, P. S., & McLaurin, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404866101 · Cited by 156 · see citing works
van Dongen, M. C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00003-9 · Cited by 155 · see citing works
Ahlemeyer, B., & Krieglstein, J. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40454 · Cited by 147 · see citing works
Wu, Z., Smith, J. V., Paramasivam, V., Butko, P., Khan, I. A., Cypser, J. R., & Luo, Y. (2002) · PubMed · Cited by 143 · see citing works
Giri, R. K., Rajagopal, V., & Kalra, V. K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02800.x · Cited by 143 · see citing works
Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Matsumoto, K., & Watanabe, H. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.170 · Cited by 141 · see citing works
Tohda, C., Matsumoto, N., Zou, K., Meselhy, M. R., & Komatsu, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300388 · Cited by 139 · see citing works
Ognibene, E., Middei, S., Daniele, S., Adriani, W., Ghirardi, O., Caprioli, A., & Laviola, G. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.028 · Cited by 135 · see citing works
Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress
Eckert, A., Keil, U., Kressmann, S., Schindowski, K., Leutner, S., Leutz, S., & Müller, W. E. G. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40449 · Cited by 132 · see citing works
Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway
Achike, F. I., & Kwan, C. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03885.x · Cited by 130 · see citing works
Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide
Zhou, L., & Zhu, X. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39323-1 · Cited by 129 · see citing works
Kanowski, S., & Hoerr, R. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45117 · Cited by 127 · see citing works
Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice
Hellström‐Lindahl, E., COURT, J. A., Keverne, J., Svedberg, M. M., Lee, M., Marutle, A., Thomas, A. J., Perry, E. K., Bednar, I., & Nordberg, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03377.x · Cited by 127 · see citing works
Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera.
Russo, A., Borrelli, F., Campisi, A., Acquaviva, R., Raciti, G., & Vanella, A. (2003) · Life Science · doi:10.1016/s0024-3205(03)00476-4 · Cited by 125 · see citing works
Lyras, L., Perry, R. H., Perry, E. K., Ince, P. G., Jenner, A. M., Jenner, P. G., & Halliwell, B. B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010302.x · Cited by 121 · see citing works
Herbs commonly used by women: An evidence-based review
Tesch, B. J. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.402 · Cited by 119 · see citing works
Duncan, A. M., Phipps, W. R., & Kurzer, M. S. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00103-3 · Cited by 118 · see citing works
A Controlled Trial of Aromatherapy for Agitation in Nursing Home Patients with Dementia
Snow, L. A., Hovanec, L., & Brandt, J. (2004) · The Journal of Alternative and Complementary Medicine · doi:10.1089/1075553041323696 · Cited by 117 · see citing works
Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial
Smallwood, J., Brown, R., Coulter, F., Irvine, E., & Copland, C. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.473 · Cited by 115 · see citing works
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P., & Perry, N. S. L. (1998) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1998.4.419 · Cited by 113 · see citing works
Merched, A. J., Sérot, J., Visvikis‐Siest, S., Aguillon, D., Faure, G. C., & Siest, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00234-8 · Cited by 111 · see citing works
Genotype and phenotype in Alzheimer's disease
Holmes, C. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.131 · Cited by 103 · see citing works
Holt, F., Birks, T. P., Thorgrimsen, L., Spector, A. E., Wiles, A., & Orrell, M. W. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003150 · Cited by 102 · see citing works
Colciaghi, F., Borroni, B., Zimmermann, M., Bellone, C., Longhi, A., Padovani, A., Cattabeni, F., Christen, Y., & Luca, M. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.011 · Cited by 102 · see citing works
The NMDA receptor ion channel: a site for binding of huperzine A
Gordon, R. K., Nigam, S. V., Weitz, J. A., Dave, J. R., Doctor, B. P., & Ved, H. S. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.805 · Cited by 100 · see citing works
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo
Perry, N. S. L., Houghton, P. J., Jenner, P. G., Keith, A. B., & Perry, E. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00082 · Cited by 98 · see citing works
Liang, Y. Q., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.071 · Cited by 96 · see citing works
Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro.
Peng, Q., Buz'Zard, A. R., & Lau, B. H. S. (2002) · PubMed · Cited by 90 · see citing works
Jia, H., Jiang, Y., Ruan, Y., Zhang, Y., Ma, X., Zhang, J., Beyreuther, K. T., Tu, P., & Zhang, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.093 · Cited by 88 · see citing works
Wong, D. M., Greenblatt, H. M., Dvir, H., Carlier, P. R., Han, Y., Pang, Y., Silman, I., & Sussman, J. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja021111w · Cited by 88 · see citing works
Effects of Green Tea Polyphenol on Cognitive and Acetylcholinesterase Activities
Kim, H. K., Kim, M., Kim, S., Kim, M., & Chung, J. H. (2004) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.68.1977 · Cited by 87 · see citing works
Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells.
Smith, J. V., Burdick, A. J., Golik, P., Khan, I. A., Wallace, D. C., & Luo, Y. (2002) · PubMed · Cited by 84 · see citing works
Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42.
Bate, C. A. W., Salmona, M., & Williams, A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-4 · Cited by 83 · see citing works
Andrieu, S., Guyonnet, S., Amouyal-Barkate, K., Nourhashémi, F., Reynish, E. L., Ousset, P., Albarède, J. L., Vellas, B. J., & Grandjean, H. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.4.m372 · Cited by 83 · see citing works
Irie, Y., & Keung, W. M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04050-7 · Cited by 80 · see citing works
Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil
Periclou, A. P., Ventura, D., Sherman, T., Rao, N. S., & Abramowitz, W. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d638 · Cited by 80 · see citing works
Holmes, C., & Ballard, C. G. (2004) · Advances in Psychiatric Treatment · doi:10.1192/apt.10.4.296 · Cited by 71 · see citing works
Zhang, H., Yan, H., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.055 · Cited by 70 · see citing works
Gasparini, L., Ongini, E., Wilcock, D. M., & Morgan, D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.029 · Cited by 68 · see citing works
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
Zimmermann, M., Borroni, B., Cattabeni, F., Padovani, A., & Luca, M. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.002 · Cited by 67 · see citing works
Kang, S. Y., Lee, K. Y., Koo, K. A., Yoon, J. S., Lim, S. W., Kim, Y. C., & Sung, S. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.07.029 · Cited by 64 · see citing works
Alternative therapies for traditional disease states: menopause.
Morelli, V., & Naquin, C. (2002) · PubMed · Cited by 63 · see citing works
Zhangjin, Z., Qian, Y., Hu, H., Yang, J., & Yang, G. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00649-0 · Cited by 62 · see citing works
Red wine micronutrients as protective agents in Alzheimer-like induced insult.
Russo, A., Palumbo, M., Aliano, C., Lempereur, L., Scoto, G. M., & Renis, M. (2003) · Life Science · doi:10.1016/s0024-3205(03)00123-1 · Cited by 62 · see citing works
Krebs, N. F. (2001) · Journal of Nutrition · doi:10.1093/jn/131.4.1351s · Cited by 61 · see citing works
Siqueira, I. R., Fochesatto, C., da Silva, A. L., Nunes, D. S., Battastini, A. M. O., Netto, C. A., & Elisabetsky, E. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00113-8 · Cited by 60 · see citing works
Gray, S., & Clair, A. A. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700305 · Cited by 56 · see citing works
Jonnala, R. R., Terry, A. V., & Buccafusco, J. J. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01529-6 · Cited by 53 · see citing works
Alzheimer's disease: the pharmacological pathway
Allain, H., Bentué‐Ferrer, D., Tribut, O., Gauthier, S. G., Michel, B., & Rochelle, C. D. L. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00153.x · Cited by 52 · see citing works
Thome, J., Gsell, W., Rösier, M., Kornhuber, J., Frölich, L., Hashimoto, E., Zielke, B., Wiesbeck, G. A., & Riedcrer, P. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00583-8 · Cited by 50 · see citing works
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants
Veurink, G. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00042-x · Cited by 48 · see citing works
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47 · see citing works
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 46 · see citing works
Zhang, J.-M., & Hu, G. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00206-8 · Cited by 45 · see citing works
Li, M. D., Kane, J. K., Matta, S. G., Blaner, W. S., & Sharp, B. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01318.2000 · Cited by 44 · see citing works
Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576
Tehranian, R., Hasanvan, H., Iverfeldt, K., Post, C., & Schultzberg, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01592-0 · Cited by 43 · see citing works
Nakagawasai, O., Yamadera, F., Iwasaki, K., Arai, H., Taniguchi, R., Tan–No, K., Sasaki, H., & Tadano, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.051 · Cited by 41 · see citing works
Heo, H.-J., Hong, S.-C., Cho, H.-Y., Hong, B., Kim, H.-K., Kim, E.-K., & Shin, D.-H. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15011-4 · Cited by 38 · see citing works
Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
Launer, L. (2003) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.289.21.2865 · Cited by 37 · see citing works
Chatterjee, S. S., Kondratskaya, E., & Krishtal, O. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40455 · Cited by 36 · see citing works
Koo, B., Lee, W.-C., Chung, K.-H., Ko, J., & Kim, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.003 · Cited by 36 · see citing works
Billion-dollar market blossoms as botanicals take root
Glaser, V. P. (1999) · Nature Biotechnology · doi:10.1038/5186 · Cited by 35 · see citing works
Rho, S., Kang, M., Choi, B., Sim, D., Lee, J., Lee, E., Cho, C., Oh, J.-W., Park, S., Ko, S., et al. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.87 · Cited by 35 · see citing works
EGb 761 is a neuroprotective agent against beta-amyloid toxicity.
Bastianetto, S., & Quirion, R. (2002) · PubMed · Cited by 35 · see citing works
Plants and the central nervous system
Houghton, P. J., & Seth, P. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00161-8 · Cited by 33 · see citing works
Response Patterns of EGb 761® in Alzheimer’s Disease: Influence of Neuropsychological Profiles
Bars, P. L. L. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40456 · Cited by 26 · see citing works
Liu, J., Cong, W., Xu, L., & Wang, J.-N. (2004) · PubMed · Cited by 23 · see citing works
Wang, H., Yang, L., & Chen, H. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00444-0 · Cited by 23 · see citing works
Zhang, Y., Zhao, X., Chen, X.-Q., Wang, Y., Yang, H., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02565-4 · Cited by 22 · see citing works
Phytoestrogens in health and illness
Rishi, R. K. (2002) · Indian Journal of Pharmacology · Cited by 20 · see citing works
Koo, B., Kim, Y., Park, K.-S., Chung, K., & Kim, C. (2004) · Phytotherapy Research · doi:10.1002/ptr.1457 · Cited by 18 · see citing works
Chen, X., Li-min, C., Zhu, Y., Fang, F., Yi-can, Z., & Zhao, C. (2003) · PubMed · Cited by 15 · see citing works
Effect of Ginkgo biloba (EGb 761®) on Differential Gene Expression
Rimbach, G. H., Wolffram, S., Watanabe, C. K., Packer, L., & Gohil, K. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40457 · Cited by 13 · see citing works
PEP Talk: Treating Nonoccupational HIV Exposure
Stephenson, J. (2003) · JAMA · doi:10.1001/jama.289.3.287 · Cited by 6 · see citing works
Bertoni–Freddari, C., Fattoretti, P., Caselli, U., Paoloni, R., & Solazzi, M. (2002) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
8 of the 176 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Resveratrol—A boon for treating Alzheimer's disease?
Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 341 · see citing works
“The enormous diversity of functions in natural compounds, such as resveratrol and other herbs, may provide a new generation of drugs for treating AD patients (Anekonda and Reddy, 2005; Bastianetto and Quirion, 2004; Howes and Houghton, 2003; Howes et al., 2003).”
BackgroundPlants traditionally used in age related brain disorders—A survey of ethnobotanical literature
Adams, M. A., Gmünder, F., & Hamburger, M. O. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.07.016 · Cited by 328 · see citing works
Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Reddy, P. H., & Reddy, T. P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745401 · Cited by 227 · see citing works
Limpeanchob, N., Jaipan, S., Rattanakaruna, S., Phrompittayarat, W., & Ingkaninan, K. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.039 · Cited by 206 · see citing works
Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
Pasinetti, G. M., & Eberstein, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05454.x · Cited by 157 · see citing works
Reddy, P. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31372 · Cited by 153 · see citing works
“Disease: Implications for Mitochondrially Targeted”
Neuronal protection by sirtuins in Alzheimer's disease
Anekonda, T. S., & Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03492.x · Cited by 150 · see citing works
“However, molecular and cellular studies suggest that aging is the main risk factor for late-onset sporadic AD (reviewed by Reddy and McWeeney 2005; Anekonda and Reddy 2005).”
BackgroundOxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 137 · see citing works
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138 · see citing works
“In animal and cell models of AD, herbal extracts appear to have fewer adverse effects than beneficial effects on cognitive functions because of their antioxidant and anti-inflammatory properties [140].”
BackgroundAnsari, N., & Khodagholi, F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040005 · Cited by 131 · see citing works
“The use of drug substances derived from natural sources has a long tradition in medicine [10, 11].”
BackgroundFang, J., Wang, L., Wu, T., Yang, C., Gao, L., Cai, H., Liu, J., Fang, S., Chen, Y., Tan, W., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.11.034 · Cited by 127 · see citing works
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works
Traditional Chinese Medicine for Senile Dementia
Lin, Z., Gu, J., Xiu, J., Mi, T., Dong, J., & Tiwari, J. K. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/692621 · Cited by 98 · see citing works
“…investigation also indicated that all the five ingredients mentioned above can elicit memory-improving effects in vivo and in vitro via multiple mechanisms of action, covering estrogenlike, cholinergic, antioxidant, anti-inflammatory, antiapoptotic, neurogenetic, and anti-Aβ activities.”
BackgroundNeuroprotective effects of Bacopa monnieri in experimental model of dementia
Saini, N., Singh, D., & Sandhir, R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0811-4 · Cited by 95 · see citing works
“Many plant products have shown beneficial effects in different AD related models as well as in clinical trials [19, 20].”
Kamal, Z., Ullah, F., Ayaz, M., Sadiq, A., Ahmad, S., Zeb, A., Hussain, A., & Imran, M. (2015) · Biological Research · doi:10.1186/s40659-015-0011-1 · Cited by 86 · see citing works
“Herbal drugs have dominance over synthetic drug because they show less toxicity, easily cross blood brain barrier and exert multiple synergistic effects [24].”
BackgroundInfluentialAnekonda, T. S., Wadsworth, T. L., Sabin, R. D., Frahler, K., Harris, C., Petriko, B., Ralle, M., Woltjer, R. L., & Quinn, J. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101287 · Cited by 84 · see citing works
“We hypothesized that PA is a CR resveratrol in plants [23–25].”
Yu, C.-J., Zheng, M., Kuang, C., Huang, W., & Yang, Q. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100684 · Cited by 85 · see citing works
“These findings provide a new direction of drug development for treating AD [42].”
BackgroundSIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway
Ramesh, S., Govindarajulu, M., Lynd, T. O., Briggs, G. H., Adamek, D., Jones, E., Heiner, J., Majrashi, M., Moore, T., Amin, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190350 · Cited by 81 · see citing works
Xiong, R., Wang, X., Wu, J., Tang, Y., Qiu, W., Shen, X., Teng, J., Pan, R., Zhao, Y., Yu, L., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112548 · Cited by 80 · see citing works
Wang, H., Dong, X., Liu, Z., Zhu, S., Liu, H., Fan, W., Hu, Y., Hu, T., Yu, Y., Li, Y., et al. (2018) · The Anatomical Record · doi:10.1002/ar.23781 · Cited by 71 · see citing works
“In recent years, increasing evidences have demonstrated that resverotrol possessed extensive biological effects, including anti-inflammatory, antioxidant, anticancer, and antiaging (Bhat et al., 2001; Anekonda and Reddy, 2005; Tsai et al., 2007).”
BackgroundNeuroprotection against Aβ25–35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells
Yu, H., Yao, L., Hongzu, Z., Qu, S., Zeng, X., Zhou, D., Zhou, Y., Li, X., & Liu, Z. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.06.001 · Cited by 69 · see citing works
Song, J., Lin, X., Wong, R. N., Sze, S. C. W., Tong, Y., Shaw, P., & Zhang, Y. (2010) · Phytotherapy Research · doi:10.1002/ptr.3269 · Cited by 68 · see citing works
“Developing new drugs from herbal medicines has emerged as an alternative for the preventive or therapeutic intervention of AD in recent years (Akhondzadeh and Abbasi, 2006; Anekonda and Reddy, 2005; Perry et al., 1999).”
BackgroundShinomol, G. K., & ., M. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.04.010 · Cited by 69 · see citing works
“Recently, herbal treatments have been used in animal and cellular models of Alzheimer’s disease (AD) and in clinical trials with AD subjects (Anekonda and Reddy, 2005).”
BackgroundDrug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia
Ho, J. Y. S., So, K., & Chang, R. C. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-15 · Cited by 65 · see citing works
“As the quality and bioavailability of a herb can be affected by the cultivation environment and harvesting season [31], single molecule approach eliminates or minimizes this variation.”
BackgroundKuo, Y., Lin, C.-Y., Li, J., & Lou, Y.-I. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128396 · Cited by 64 · see citing works
Lee, J. W., Lee, Y. K., Lee, B. J., Nam, S.-Y., Lee, S. I., Kim, Y. H., Kim, K. H., Oh, K., & Hong, J. T. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.12.003 · Cited by 62 · see citing works
“Several cellular changes by oxidative stresses have been related with Aβ plaques formation and pathophysiological events of AD (Anekonda and Reddy, 2005).”
BackgroundMajlessi, N., Choopani, S., Kamalinejad, M., & Azizi, Z. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00237.x · Cited by 61 · see citing works
“In AD animal and cellular models, herbal extracts appear to have fewer adverse effects than beneficial effects on cognitive function [20,54].”
BŁACH-OLSZEWSKA, Z., & Leszek, J. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a906 · Cited by 60 · see citing works
“Several reports have been published on the effi ciency of natural immunosuppressive drugs in AD treatment (Anekonda and Redy 2005).”
Memory-improving activity of Melissa officinalis extract in naïve and scopolamine-treated rats.
Soodi, M., Naghdi, N., Hajimehdipoor, H., Choopani, S., & Sahraei, E. (2014) · Europe PMC (PubMed Central) · Cited by 56 · see citing works
Wang, X., Wu, J., Yu, C., Tang, Y., Liu, J., Chen, H., Jin, B., Mei, Q., Cao, S., & Qin, D. (2017) · Nutrients · doi:10.3390/nu9020105 · Cited by 56 · see citing works
“Natural products and medicinal herbs are important source of protective compounds against AD and the use of drug substances derived from natural sources has a long tradition in medicine [24,25].”
BackgroundYang, Z., Zhang, X., Du, J., Ma, Z.-J., Guo, F., Li, S., & Yao, X. (2011) · Natural Product Research · doi:10.1080/14786419.2010.487188 · Cited by 55 · see citing works
“…that can increase the cholinergic transmission by blocking the degradation of ACh are therefore considered to be a promising approach for the treatment of Alzheimer’s disease, ataxia, myasthenia gravis and Parkinson’s disease (Anekonda & Reddy, 2005; Mukherjee, Kumar, Mal, & Houghton, 2007a).”
MethodSivaraman, D., Panneerselvam, P., & Palayan, M. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.50203 · Cited by 55 · see citing works
“The study related to Alzheimer’s disease (AD) is focused towards the traditionally used rejuvenating and neurotonic agents (Thimmappa et al., 2005).”
BackgroundNwidu, L. L., Elmorsy, E. M., Thornton, J., Wijamunige, B. C., Wijesekara, A., Tarbox, R., Warren, A. Y., & Carter, W. G. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1339283 · Cited by 53 · see citing works
Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action
Saini, N., Singh, D., & Sandhir, R. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0332-1 · Cited by 51 · see citing works
BŁACH-OLSZEWSKA, Z., Jatczak, B., Rak, A., Lorenc, M., Gulanowski, B., Drobna, A., & Lamer-Zarawska, E. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0125 · Cited by 51 · see citing works
“According to literature data, S. baicalensis is able to influence neurodegenerative diseases by suppressing neuron death (Kim and others 2001; Lee and others 2003; Li and others 2005; Anekonda and Reddy 2005; Suk 2005; Shang and others 2006).”
Sun, Y., Zhu, R., Ye, H., Tang, K., Zhao, J., Chen, Y., Liu, Q., & Cao, Z. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs025 · Cited by 49 · see citing works
“The use of herbal medicines in the treatment of AD is attracting more and more attention [12, 13], and some of which have even advanced to clinical trials.”
BackgroundFlavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go
Prasanna, P., & Upadhyay, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00224 · Cited by 46 · see citing works
Critical Evaluation of Ayurvedic Plants for Stimulating Intrinsic Antioxidant Response
Shukla, S. D., Bhatnagar, M., & Khurana, S. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00112 · Cited by 45 · see citing works
“CONCLUSION While ayurvedic plants have been explored for many passive antioxidants and medical uses for serious neurological diseases such as Alzheimer’s disease (Anekonda and Reddy, 2005), a systematic analysis for the herbs covered in this review for the ability to increase body’s ability to reduce antioxidant stres…”
BackgroundRapaka, D., Bitra, V., Vishala, T. C., & Akula, A. (2018) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.06.013 · Cited by 34 · see citing works
“Apart from these activities, Vitis prevents DNA and RNA fragmentation [29] besides its high antioxidant capacity, such that the structural modifications of cholinergic receptors may be prevented.”
BackgroundNootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease
Vyas, S., Kothari, S. L., & Kachhwaha, S. (2019) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2019.100291 · Cited by 44 · see citing works
Tang, Y., Yu, C., Wu, J., Chen, H., Zeng, Y., Wang, X., Yang, L., Mei, Q., Cao, S., & Qin, D. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3245 · Cited by 43 · see citing works
“Natural products and medicinal herbs are important sources for drug discovery against various diseases including AD and T2DM (55).”
BackgroundAliev, G. M., Palacios, H. H., Gasimov, E. K., Obrenovich, M. E., Morales, L., Leszek, J., Bragin, V., Herrera, A. S., & Gokhman, D. (2010) · Pharmaceuticals · doi:10.3390/ph3010158 · Cited by 43 · see citing works
Parameswari, A. R., Rajalakshmi, G., & Kumaradhas, P. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.011 · Cited by 38 · see citing works
Zheng, Y., Cheng, X., Zhou, W., & Zhang, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.009 · Cited by 36 · see citing works
Tu, L.-H., Ma, J., Liu, H., Wang, R.-R., & Luo, J. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9421-3 · Cited by 36 · see citing works
“It has been used in traditional antioxidant therapies of aging (King 1986; Anekonda and Reddy 2005; Nie et al. 2008).”
MethodPreclinical evaluation of Trichilia catigua extracts on the central nervous system of mice
Chassot, J. M., Longhini, R., Gazarini, L., de Mello, J. C. P., & de Oliveira, R. M. W. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.07.032 · Cited by 34 · see citing works
“The mechanistic basis of the pharmacological activity of antioxdants are multifunctional and may involve its general free radical cavenge ability (Anekonda and Reddy, 2005).”
BackgroundRusso, P., Frustaci, A., Bufalo, A. D., Fini, M., & Cesario, A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320080002 · Cited by 33 · see citing works
“Several studies report the use of "traditional plants" for treatment of dementia and AD [50-68].”
BackgroundKandasamy, S., Kalaiarasi, C., & Kumaradhas, P. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1264891 · Cited by 33 · see citing works
“…Sabbagh, 2008) and tacrine (Tumiatti et al., 2010) are the reported inhibitors of AChE, and are being used for the treatment of AD (Babitha et al., 2014; Murray, Faraoni, Castro, Alza, & Cavallaro, 2013; Narandra, Pandey, & Pankaj, 2011; Singh et al., 2010; Stefano, 2013; Thimmappa & Reddy, 2005).”
MethodAkter, R., Chowdhury, M. A. R., & Rahman, M. H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201102102810 · Cited by 33 · see citing works
Singh, H. K. (2013) · Nutrients · doi:10.3390/nu5020478 · Cited by 32 · see citing works
Ji, C., Aisa, H. A., Yang, N., Li, Q., Wang, T., Zhang, L., Qu, K., Zhu, H., & Zuo, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14302 · Cited by 30 · see citing works
“The identification of GHE components and profiling of its metabolites have been investigatedbefore [3,11].”
Small Molecule Natural Products and Alzheimer’s Disease
Wu, X., Cai, H., Pan, L., Cui, G., Qin, F., Li, Y., & Cai, Z. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190201153257 · Cited by 29 · see citing works
Zhu, H., Ding, L., Shakya, S., Qi, X., Hu, L., Yang, X., & Yang, Z. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.09.014 · Cited by 30 · see citing works
Ren, X., Chen, H., Wang, H., Wang, Y., Huang, C., & Pan, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118262 · Cited by 28 · see citing works
Ginger, a Possible Candidate for the Treatment of Dementias?
Schepici, G., Contestabile, V., Valeri, A., & Mazzon, E. (2021) · Molecules · doi:10.3390/molecules26185700 · Cited by 29 · see citing works
“Nowadays, limited approved therapies are available for dementia, thus natural compounds such as ginger could be useful for the treatment of AD [32].”
BackgroundSepand, M. R., Soodi, M., Hajimehdipoor, H., Soleimani, M., & Sahraei, E. (2013) · Europe PMC (PubMed Central) · Cited by 27 · see citing works
Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer’s disease
Kumar, A., Sharma, V., Singh, V. P., Kaundal, M., Gupta, M., Bariwal, J. B., & Deshmukh, R. R. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.05.009 · Cited by 27 · see citing works
Floris, S., Fais, A., Rosa, A., Piras, A., Marzouki, H., Medda, R., Paramás, A. M. G., Kumar, A., Santos‐Buelga, C., & Era, B. (2019) · RSC Advances · doi:10.1039/c9ra02928a · Cited by 25 · see citing works
Fereidooni, F., Komeili, G., Fanaei, H., Safari, T., Khorrami, S., & Feizabad, A. K. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.08.001 · Cited by 25 · see citing works
Murata, K., Iida, D., Ueno, Y., Samukawa, K., Ishizaka, T., Kotake, T., & Matsuda, H. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-1036-7 · Cited by 24 · see citing works
Lomarat, P., Sripha, K., Phanthong, P., Kitphati, W., Thirapanmethee, K., & Bunyapraphatsara, N. (2015) · The Thai Journal of Pharmaceutical Sciences · doi:10.56808/3027-7922.1951 · Cited by 24 · see citing works
“th/tjps TJPS 2015, 39 (3): 94-101 proteins Aβ1-40 and Aβ1-42, and tau-based neurofibrillary tangles [1-3].”
BackgroundAzizi, Z., Majlessi, N., Choopani, S., & Naghdi, N. (2022) · PubMed Central · doi:10.22038/ajp.2022.19491 · Cited by 23 · see citing works
Seo, J., Jung, E.-Y., Kim, J., Lyu, Y.-S., Han, P., & Kang, H.-W. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.05.055 · Cited by 23 · see citing works
Han, J., Zhang, H., Zhang, Y., Zhang, Z., Yu, M., Wang, S., & Han, F. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115194 · Cited by 22 · see citing works
Figueiró, M., Ilha, J., Pochmann, D., Porciúncula, L. O., Xavier, L. L., Achaval, M., Nunes, D. S., & Elisabetsky, E. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.03.009 · Cited by 22 · see citing works
Barai, P., Raval, N., Acharya, S., & Acharya, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.011 · Cited by 21 · see citing works
Anti-aggregation effects of thymoquinone against Alzheimers -amyloid in vitro
Ismail, N., Ismail, M., Shahid, I., & Latiff, L. A. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr10.852 · Cited by 21 · see citing works
“But these drugs can only treat the cognitive and behavioral symptoms of AD (Anekonda and Reddy, 2005), causing some side effects such as hepatotoxicity and peripheral cholinergic effects (Benzi and Moretti, 1998).”
Herbal approaches to system dysfunctions
(2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06992-5.00009-8 · Cited by 20 · see citing works
Zhang, C., Zhao, X., Lin, S., Liu, F., Ma, J., Han, Z., Jia, F., Xie, W., Zhang, Q., & Li, X. (2019) · Molecules · doi:10.3390/molecules25010142 · Cited by 20 · see citing works
“Herbal medicines comprising varied components exhibit many pharmacological activities including anti-oxidant, anti-amyloid, and anti-inflammation and so on [25].”
BackgroundMajid, H., & Silva, F. (2020) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2020.1741403 · Cited by 20 · see citing works
de Souza, S. P., Roos, A. A., Gindri, A. L., Domingues, V. O., Ascari, J., & Guerra, G. P. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103958 · Cited by 20 · see citing works
Zhang, R., Zhu, H., Ding, L., & Yang, Z. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.03.030 · Cited by 18 · see citing works
Antioxidant and Astroprotective Effects of a Pulicaria incisa Infusion
Elmann, A., Telerman, A., Mordechay, S., Erlank, H., & Ofir, R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/157598 · Cited by 18 · see citing works
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2012, Article ID 157598, 10 pages doi:10.1155/2012/157598”
BackgroundInfluentialGossypium herbaceam Extracts Attenuate Ibotenic Acid-induced Excitotoxicity in Rat Hippocampus
Ji, C., Li, Q., Aisa, H., Yang, N., Dong, Y., Liu, Y., Wang, T., Hao, Q., Zhu, H., & Zuo, P. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0979 · Cited by 17 · see citing works
“The identification of GHE components and profiling of its metabolites have been investigated recently [18, 19].”
Soodi, M., Dashti, A., Hajimehdipoor, H., Akbari, S., & Ataei, N. (2017) · PubMed Central · doi:10.22074/cellj.2016.4722 · Cited by 16 · see citing works
“Herbal medicines contain a number of components with different pharmacological effects (pro-cholinergic, antioxidant, anti-amyloid, and anti-inflammatory) and may be more effective in treatment of complex diseases (7).”
BackgroundTherapeutic effect of Melissa officinalis in an amyloid-β rat model of Alzheimer’s disease
Beheshti, S., & Shahmoradi, B. (2018) · Journal of Herbmed Pharmacology · doi:10.15171/jhp.2018.31 · Cited by 16 · see citing works
“Hence, several studies have been considered to evaluated therapeutic effects of herbal medicines in AD therapy (9).”
BackgroundMethodMoxibustion for cognitive impairment: A systematic review and meta-analysis of animal studies
Aum, S., Choe, S., Cai, M., Jerng, U. M., & Lee, J. (2020) · Integrative Medicine Research · doi:10.1016/j.imr.2020.100680 · Cited by 15 · see citing works
Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment
Casadesús, G., Puig, E. R., Webber, K. M., Atwood, C., Escuer, M. C., Bowen, R. L., Perry, G. L., & Smith, M. A. (2006) · BioMed Research International · doi:10.1155/jbb/2006/39508 · Cited by 15 · see citing works
“Resveratrol, a potent antioxidant of natural origin [66–69], may be of benefit in murine senescence and AD models and in some clinical studies in patients with AD [70].”
BackgroundBotanical Phenolics and Neurodegeneration
Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2011) · Oxidative stress and disease · doi:10.1201/b10787-16 · Cited by 15 · see citing works
Plant-derived natural products as leads for drug discovery
Pan, L., de Blanco, E. J. C., & Kinghorn, A. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-85498-4_24 · Cited by 14 · see citing works
Maheep, B., Prahlad, M., Satyendra, B., & Chetan, J. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.497 · Cited by 14 · see citing works
Shakerin, Z., Esfandiari, E., Ghanadian, M., Razavi, S., Alaei, H., & Dashti, G. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00493-2 · Cited by 14 · see citing works
Qiao, Y., Liu, H., He, C., & Ma, Y. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.11.023 · Cited by 13 · see citing works
Kandasamy, S., Karthikeyan, S., Sugarthi, S., & Stephen, A. D. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.119856 · Cited by 12 · see citing works
Camptothecin and its Analogs Reduce Amyloid-β Production and Amyloid-β42-Induced IL-1β Production
Wang, J., Shi, Z., Zhang, M., Xin, G.-Z., Pang, T., Zhou, P. H., Chen, J., Qi, L., Yang, H. Q., Xu, X., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140078 · Cited by 12 · see citing works
“The chemical compositions of herbs and their potency for alleviating or reducing symptoms of AD or for affecting the disease mechanism need to be further studied [30].”
BackgroundAdewusi, E. A., & Steenkamp, V. (2015) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(15)60810-6 · Cited by 12 · see citing works
“longa In vivo Tg2576 mice Inhibition of oligomer and fibril formation Anekonda and Reddy[103], Yang et al.”
BackgroundBahaeddin, Z., Yans, A., Khodagholi, F., & Sahranavard, S. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0585 · Cited by 12 · see citing works
Sivakumar, M., Kandasamy, S., Saravanan, V., Sugarthi, S., kumar, S. M., Isa, M. A., Rajakumar, P., & Aravindhan, S. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1620128 · Cited by 12 · see citing works
“There are four drugs available to control the AChE activity for treatment of AD patients and several drugs are under clinical study (Murray et al., 2013; Anekonda & Reddy, 2005; Ker€anen et al., 2017; Thaisrivongs et al., 2016; Cohen & Frame, 2001; Bhat et al., 2003; Calcul et al., 2012).”
BackgroundQuan, Y., Li, X., Pang, L., Deng, H., Chen, F., Lee, J. J., Quan, Z., Liu, P., Guo, H., & Shen, Q. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106977 · Cited by 11 · see citing works
In vitro Acetyl Cholinesterase Inhibitory assay of Acacia catechu Willd Ethanolic Seed Extract
Thangavelu, L. P., & Ramasamy, R. (2015) · Pharmacognosy Journal · doi:10.5530/pj.2015.5.5 · Cited by 11 · see citing works
Kandasamy, S., Sivanandam, M., Hunday, G., Pavan, M. S., & Kumaradhas, P. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.07.019 · Cited by 11 · see citing works
Costa, G. F. C. E., Nishijo, H., Caixeta, L. F., & Aversi‐Ferreira, T. A. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7686913 · Cited by 10 · see citing works
He, M. T., Kim, J.-H., Kim, J. H., Park, C. H., & Cho, E. J. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104048 · Cited by 10 · see citing works
Lim, M. K., Lee, S., Kim, J. Y., Jeong, J., Han, E. H., Lee, S. H., Ryu, J. H., & Lee, J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104400 · Cited by 10 · see citing works
Pulicaria incisa infusion attenuates inflammatory responses of brain microglial cells
Elmann, A., Beit‐Yannai, E., Telerman, A., Ofir, R., Mordechay, S., Erlank, H., & Borochov‐Neori, H. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.05.012 · Cited by 10 · see citing works
Nourbakhsh, F., Read, M. I., Barreto, G. E., & Sahebkar, A. (2020) · IUBMB Life · doi:10.1002/iub.2369 · Cited by 10 · see citing works
“summarized in the following sections (Table 1).(107,108) Furthermore, this review assesses the research on various medicinal plants, which have demonstrated promise in reversing the AD pathology.”
BackgroundMahita, M. (2014) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2014/9397 · Cited by 9 · see citing works
“These (EOs) demonstrated significant effects in reduction of agitation, wandering, insomnia and social withdrawal [9,10,3].”
BackgroundXie, Y.-C., Ning, N., Zhu, L., Li, D., Feng, X., & Yang, X. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7481323 · Cited by 9 · see citing works
“AChE inhibitors can increase the cholinergic transmission by blocking the degradation of ACh and are therefore considered to be a promising approach for the treatment of Alzheimer’s disease [8].”
BackgroundShakya, S., Zhu, H., Ding, L., Du, X. L., Qi, X. M., Yang, X., & Yang, Z. L. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1634 · Cited by 8 · see citing works
Liu, Y., Aisa, H. A., Ji, C., Yang, N., Zhu, H., & Zuo, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112153 · Cited by 8 · see citing works
“The identification of GHE components and profiling of its metabolites have been investigated recently [15, 16].”
- Authors
- Anekonda, T. S., & Reddy, P. H.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Reddy, P. Hemachandra
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 50
- Issue
- 2
- Pages
- 361-376
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W1991124307
- Cited by
- 140
- References
- 176
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 12 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 10 · 2013: 10 · 2012: 6
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r03ag022643-01)
- National Institute on Aging (AG 22643)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, herbal medicine, amyloid-beta, amyloid plaques, neurofibrillary tangles, anti-amyloid therapy, anti-inflammatory therapy, antioxidant therapy, cognitive function, plant extracts, animal models of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Disease Models, Animal, Humans, Plant Extracts, Herbal Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review